Clinical and pathophysiological characteristics of valproate-induced pleural effusion.
Tryfon S, Papadopoulou E, Saroglou M, Vlachopoulos D, Georgopoulou A, Serasli E, Ismailos G.
Tryfon S, et al.
Clin Toxicol (Phila). 2021 Oct;59(10):869-876. doi: 10.1080/15563650.2021.1945081. Epub 2021 Jul 14.
Clin Toxicol (Phila). 2021.
PMID: 34259092
Interestingly, a patient presented with recurrent pleural effusion characterized by transition from eosinophilic to lymphocytic predominance after readministration of valproate. TRANSUDATIVE PLEURAL EFFUSION: Three out of 28 cases (10.7%) were characterized b …
Interestingly, a patient presented with recurrent pleural effusion characterized by transition from eosinophilic to lymphocytic predominance …